Science1 publisher3 min readPublished Updated
Viral RNA snippets triple linear mRNA half-life in cells, IBS team reports in Cell
A screen of 337 virus genomes found stabilizing elements; one, Pt1, pushed linear mRNA half-life from 7.6 to 23.1 hours by recruiting nuclear poly(A) polymerases in the cytoplasm.
The Scientist · Science desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction

What happened
- A research team led by Director Kim V. Narry at the Center for RNA Research within the Institute for Basic Science (IBS) discovered compact viral RNA elements that can make mRNA more stable and increase protein production.
- The study was published in the journal Cell.
- Conventional mRNA is inherently short-lived and is rapidly degraded inside cells, often limiting protein production to a relatively short period; a major factor determining stability is the poly(A) tail, and as the tail shortens the mRNA becomes increasingly vulnerable to degradation.
- Delivering synthetic mRNA into cells temporarily turns them into protein-producing factories; this principle enabled COVID-19 mRNA vaccines and holds promise for cancer immunotherapy and treatments replacing proteins that are missing or insufficient.
- The researchers divided genomes from 337 vertebrate-infecting viruses into nearly 200,000 short segments and tested how each affected mRNA abundance, translation and protein production; the screen revealed hundreds of viral RNA segments capable of enhancing gene expression.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
A team at the Institute for Basic Science's Center for RNA Research, led by Director Kim V. Narry, has reported in Cell a set of compact viral RNA elements that make mRNA more stable and raise protein output [1][2]. That matters because the short life of mRNA inside cells is one of the hard constraints on dosing for vaccines and protein-replacement therapies, and this result frames it as a sequence-design problem rather than a property of the molecule [4][18].
The approach was brute force. The researchers cut genomes from 337 vertebrate-infecting viruses into nearly 200,000 short segments, roughly 590 per genome, and measured each one's effect on mRNA abundance, translation and protein production [5][17]. Hundreds of segments increased gene expression [5].
Many of the hits worked through a single host enzyme, terminal nucleotidyltransferase 4, which slows degradation by extending the poly(A) tail through mixed tailing [6]. The team pinned down 23 TENT4-dependent elements spread across 19 viral genera and sorted them into six types by sequence, structure and cofactor use [7]. They call elements that promote poly(A)-tail extension "tailons" [8]. Nineteen genera converging on the same host machinery by six structural routes is the more interesting scientific finding here: it suggests the pathway is unusually easy for evolution to find, and by extension for engineers to reuse [7].
The most potent element, Pt1, does not use TENT4 at all [9]. Derived from Potamipivirus, it directly recruits poly(A) polymerase gamma and poly(A) polymerase alpha [9][10]. Those enzymes are known for tailing pre-mRNA in the nucleus; the researchers report that a fraction of both sits in the cytoplasm, where Pt1 pulls them in to extend the tail after transcription [11]. If that holds up, it is a new job description for a well-studied pair of enzymes [11].
The practical comparison is against circular RNA, which resists degradation because its ends are joined but produces protein less efficiently and is harder to manufacture [12]. In cultured cells, conventional linear mRNA had a half-life of about 7.6 hours, linear mRNA carrying Pt1 reached 23.1 hours, and circular RNA 24.9 hours [13]. That is roughly a threefold gain for a single inserted element [14], landing at about 93 percent of the circular benchmark while keeping linear mRNA's translation efficiency and simpler production [15][12].
Two caveats sit on the face of the report. The half-life comparison is in cultured cells [13], and the announcement does not extend it to animals or to dose-sparing in a formulated product [16]. The researchers also point to earlier work of their own in Nature Biotechnology, though the available description of that study is incomplete [19].
What to watch: whether the 23.1-hour figure survives lipid-nanoparticle delivery and in vivo measurement, where nuclease environments and innate immune sensing differ from a dish [13]; whether longer-lived mRNA translates into lower doses rather than merely longer expression [18]; and whether recruiting PAPγ and PAPα into cytoplasmic tailing perturbs the cell's own mRNA pool, since those enzymes have day jobs [10][11]. The six tailon classes also give developers a menu rather than a single sequence, which matters if any one element proves immunogenic or patent-encumbered [7].